67 results
Page 2 of 4
6-K/A
EX-99.2
7wnazof8ks
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.5
b0oc2l7iahzv7z5qr
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
vii0p5px
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.5
jdt45ds
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
yl1w2t3
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
EX-4.1
bepi16 dkvkst
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-4.2
zht6 a55vuudlq
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-1.1
9hh2hoyv j3jvls
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
UPLOAD
grq9s36xe8w2wt
8 Aug 19
Letter from SEC
12:00am
F-3
EX-4.6
xxv434bj6elo6a
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-4.2
kkxvu8t57x ll48
7 Aug 19
Shelf registration (foreign)
8:24am